semaglutide blood in urine and UTI: does GLP-1 therapy increase urinary tract infection risk? Effects of Semaglutide on Albuminuria

However, this risk increases when Ozempic is used in combination with insulin or sulfonylureas

The SURMOUNT-5 trial directly compared the two medications and found tirzepatide produced approximately 20 percent weight loss compared to 14 percent for semaglutide

Year 1 (currently active) restricts access to adults aged 18 to 75 with a BMI of 40 or above, with at least four of five qualifying conditions 4

Cost is roughly comparable across formats

Semaglutide, a GLP-1 receptor agonist approved by the FDA for type 2 diabetes and chronic weight management, significantly affects appetite and digestion by slowing gastric emptying and reducing hunger signals